Edwards Lifesciences Corp (EW)
67.43 x 100 71.80 x 200
Post-market by (Cboe BZX)
72.05 +0.18 (+0.25%) 04/02/25 [NYSE]
67.43 x 100 71.80 x 200
Post-market 70.50 -1.55 (-2.15%) 18:18 ET
for Wed, Apr 2nd, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,179,100 | 714,100 | 818,300 | 930,100 | 718,400 |
| Marketable Securities | 337,800 | 242,400 | 519,200 | 341,000 | 506,300 |
| Receivables | 599,100 | 537,300 | 479,300 | 414,600 | 371,800 |
| Inventories | 640,900 | 607,000 | 554,900 | 396,600 | 339,900 |
| Other current assets | 168,000 | 131,800 | 116,900 | 111,800 | 66,400 |
| TOTAL | $2,984,000 | $2,286,900 | $2,549,200 | $2,240,000 | $2,047,900 |
| Non-Current Assets | |||||
| PPE Net | 1,060,300 | 867,500 | 679,700 | 580,000 | 482,500 |
| Investments And Advances | 585,500 | 0 | 567,000 | 532,100 | 379,900 |
| Intangibles | 1,504,200 | 1,455,400 | 1,594,500 | 830,900 | 833,700 |
| Other Non-Current Assets | 354,100 | 713,900 | 276,000 | 327,000 | 312,300 |
| TOTAL | $3,504,100 | $3,036,800 | $3,117,200 | $2,270,000 | $2,008,400 |
| Total Assets | $6,488,100 | $5,323,700 | $5,666,400 | $4,510,000 | $4,056,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 598,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 180,400 | 134,000 | 116,600 | 97,100 | 63,900 |
| Accrued Expenses | 696,500 | 742,600 | 653,700 | 435,400 | 412,300 |
| Other current liabilities | N/A | N/A | 51,700 | N/A | N/A |
| TOTAL | $902,400 | $876,600 | $1,420,000 | $532,500 | $476,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 594,400 | 593,800 | 438,400 | 822,300 | 596,900 |
| aiOther Non-Current Liabilities | 843,000 | 712,900 | 851,800 | 536,200 | 480,100 |
| TOTAL | $1,437,400 | $1,306,700 | $1,290,200 | $1,358,500 | $1,077,000 |
| Total Liabilities | $2,339,800 | $2,183,300 | $2,710,200 | $1,891,000 | $1,553,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 627,368 | 623,299 | 630,071 | 637,487 | 643,793 |
| Common Shares | 218,100 | 215,200 | 212,000 | 242,600 | 239,100 |
| Retained earnings | 3,741,600 | 2,694,700 | 1,962,100 | 3,906,300 | 3,336,800 |
| Other shareholders' equity | -155,700 | -138,900 | -132,800 | -198,700 | -182,600 |
| TOTAL | $4,148,300 | $3,140,400 | $2,956,200 | $2,619,000 | $2,503,100 |
| Total Liabilities And Equity | $6,488,100 | $5,323,700 | $5,666,400 | $4,510,000 | $4,056,300 |